Related Experiment Video
Updated: Jan 19, 2026

05:04
Application of Passive Head Motion to Generate Defined Accelerations at the Heads of Rodents
Published on: July 21, 2022
2.2K
Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice
Ruiqi Pang1, Xiaofan Wang1, Feifei Pei1
1School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.
Journal of Alzheimer'S Disease : JAD
|September 29, 2019
Summary
Regular exercise improved Alzheimer's disease (AD) mouse models by boosting brain energy metabolism, increasing glucose transporters (GLUTs), and enhancing cognitive function. This suggests exercise is a promising therapeutic strategy for AD.
Area of Science:
- Neuroscience
- Metabolic Research
- Gerontology
Background:
- Alzheimer's disease (AD) is characterized by impaired brain energy metabolism, contributing to cognitive decline.
- Glucose transporters (GLUTs) are critical for maintaining brain energy homeostasis, and their deficiency impacts neuronal function.
- GLUT1 deficiency in mice is linked to synapse loss and mitochondrial abnormalities.
Purpose of the Study:
- To investigate the therapeutic potential of regular exercise (RE) on brain energy metabolism and cognitive function in Alzheimer's disease (AD) mouse models.
- To examine the effects of RE on key AD pathologies, including amyloid-β and phosphorylated tau.
- To assess the impact of RE on glucose transporter expression (GLUT1 and GLUT3) and synaptic integrity in the central nervous system (CNS).
Main Methods:
- Western blot analysis to quantify amyloid-β and phosphorylated tau levels.
- Morris water maze test to evaluate spatial learning and memory.
- Assessment of mitochondrial morphology, ATP production, synapse counts, and GLUT1/GLUT3 expression in the CNS.
Main Results:
- Regular exercise (RE) reduced amyloid-β and phosphorylated tau levels in AD model mice.
- RE enhanced spatial learning and exploration abilities.
- Mitochondrial structure improved, ATP production increased, synapse numbers rose, and GLUT1/GLUT3 expression was upregulated in the CNS of AD mice following RE.
Conclusions:
- Regular exercise positively impacts brain energy metabolism and synaptic plasticity in Alzheimer's disease models.
- Improved GLUT1 and GLUT3 expression following RE is a key adaptation for enhanced cerebral energy metabolism.
- The findings highlight RE as a promising non-pharmacological intervention for Alzheimer's disease, improving cognitive function through enhanced brain energy metabolism and neuronal integrity.
Related Concept Videos
Alzheimer's Disease: Treatment
827
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
827
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
563
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
563
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K

